cilengitide has been researched along with Angiogenesis, Pathologic in 20 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (5.00) | 18.2507 |
| 2000's | 5 (25.00) | 29.6817 |
| 2010's | 14 (70.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bazzazi, H; Jafarnejad, M; Popel, AS; Zhang, Y | 1 |
| Date, I; Ichikawa, T; Kurozumi, K; Onishi, M | 2 |
| Carme, S; Ceelen, W; De Naeyer, D; Debergh, I; Demetter, P; Pattyn, P; Robert, P; Smeets, P; Van Damme, N | 1 |
| Ameratunga, MS; Grant, R; Khasraw, M; Pavlakis, N; Wheeler, H | 1 |
| Ahn, H; Amorós, M; Bolontrade, M; Cayrol, F; Cerchietti, L; Cremaschi, GA; Díaz Flaqué, MC; Farías, RN; Fernando, T; Inghirami, G; Isse, B; Singh, A; Sterle, HA; Tabbò, F; Tian, YF; Yang, SN | 1 |
| Alrawashdeh, W; Cereser, B; Crnogorac-Jurcevic, T; Demircioglu, F; Elia, G; Ghazaly, E; Hagemann, T; Hodivala-Dilke, KM; Kocher, HM; McDonald, S; Scudamore, CL; Stratford, MR; Wong, PP | 1 |
| Cohen, EE; Fleming, GF; Harris, PJ; Janisch, L; Karovic, S; Karrison, TG; Levine, MR; Maitland, ML; O'Donnell, PH; Polite, BN; Ratain, MJ | 1 |
| Bergers, G; Rivera, LB | 1 |
| Date, I; Ichikawa, T; Ishida, J; Kurozumi, K; Shimizu, T | 1 |
| Gramatzki, D; Roth, P; Seystahl, K; Weller, M | 1 |
| Nabors, B; Reardon, D; Stupp, R; Weller, M | 1 |
| Imaizumi, N; Kuonen, F; Monnier, Y; Rüegg, C | 1 |
| Bäuerle, T; Bretschi, M; Cheng, C; Dimitrakopoulou-Strauss, A; Semmler, W; Strauss, LG; Witt, H | 1 |
| DeWitt, JP; Han, JH; Kim, B; Kim, CY; Kim, SK; Kim, YH; Lee, JE; Lee, JK; Oh, CW | 1 |
| Dubowitz, DJ; Fraser, S; Gonzalez-Gomez, I; Jacobs, R; Khankaldyyan, V; Laug, WE; Moats, RA; Nelson, MD; Schultz, L; Taga, T; Velan-Mullan, S | 1 |
| Goodman, SL; Jonczyk, A; Nisato, RE; Pepper, MS; Tille, JC | 1 |
| Akella, NS; Cloud, GA; Grossman, S; Hochberg, FH; Mikkelsen, T; Nabors, LB; Twieg, DB | 1 |
| Bu, XY; Gonzales-Gomez, I; Khankaldyyan, V; Laug, WE; McComb, JG; Yamada, S | 1 |
| Cheresh, DA; Gillies, SD; Jonczyk, A; Lode, HN; Moehler, T; Reisfeld, RA; Xiang, R | 1 |
5 review(s) available for cilengitide and Angiogenesis, Pathologic
| Article | Year |
|---|---|
Mechanisms of tumor development and anti-angiogenic therapy in glioblastoma multiforme.
Topics: Angiogenesis Inhibitors; Animals; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Bevacizumab; Brain Neoplasms; Cell Adhesion; Combined Modality Therapy; Glioblastoma; Humans; Integrin alphaVbeta3; Neoplasm Invasiveness; Neoplasm Proteins; Neovascularization, Pathologic; Snake Venoms; Vascular Endothelial Growth Factor A | 2013 |
Antiangiogenic therapy for high-grade glioma.
Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Bevacizumab; Brain Neoplasms; Camptothecin; Dacarbazine; Glioblastoma; Humans; Hypertension; Irinotecan; Lomustine; Neoplasm Recurrence, Local; Neovascularization, Pathologic; Proteinuria; Randomized Controlled Trials as Topic; Snake Venoms; Temozolomide | 2014 |
Adhesion molecules and the extracellular matrix as drug targets for glioma.
Topics: Angiogenesis Inhibitors; Antibodies; Brain Neoplasms; Cell Adhesion Molecules; Disease Progression; Extracellular Matrix; Glioma; Humans; Molecular Targeted Therapy; Neoplasm Invasiveness; Neovascularization, Pathologic; Snake Venoms; Thalidomide; White Matter | 2016 |
Pharmacotherapies for the treatment of glioblastoma - current evidence and perspectives.
Topics: Bevacizumab; Brain Neoplasms; Combined Modality Therapy; Dacarbazine; Glioblastoma; Humans; Neovascularization, Pathologic; Snake Venoms; Temozolomide | 2016 |
Angiogenesis and invasion in glioma.
Topics: Angiogenesis Inhibitors; Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Brain Neoplasms; Disease Models, Animal; Endothelial Cells; Extracellular Matrix; Glioma; Humans; Mice; Molecular Targeted Therapy; Neoplasm Invasiveness; Neovascularization, Pathologic; Rats; Snake Venoms; Tenascin; Thalidomide | 2011 |
2 trial(s) available for cilengitide and Angiogenesis, Pathologic
| Article | Year |
|---|---|
Serum C-Telopeptide Collagen Crosslinks and Plasma Soluble VEGFR2 as Pharmacodynamic Biomarkers in a Trial of Sequentially Administered Sunitinib and Cilengitide.
Topics: Adult; Aged; Aged, 80 and over; Angiogenesis Inhibitors; Biomarkers, Tumor; Collagen Type I; Female; Humans; Indoles; Male; Middle Aged; Neoplasm Staging; Neoplasms; Neovascularization, Pathologic; Peptides; Pyrroles; Snake Venoms; Sunitinib; Vascular Endothelial Growth Factor Receptor-2 | 2015 |
Assessment of brain tumor angiogenesis inhibitors using perfusion magnetic resonance imaging: quality and analysis results of a phase I trial.
Topics: Angiogenesis Inhibitors; Blood Flow Velocity; Blood Volume; Brain Neoplasms; Disease Progression; Echo-Planar Imaging; Glioblastoma; Glioma; Humans; Magnetic Resonance Angiography; Neoplasm Recurrence, Local; Neovascularization, Pathologic; Peptides, Cyclic; Snake Venoms | 2004 |
13 other study(ies) available for cilengitide and Angiogenesis, Pathologic
| Article | Year |
|---|---|
Computational modeling of synergistic interaction between αVβ3 integrin and VEGFR2 in endothelial cells: Implications for the mechanism of action of angiogenesis-modulating integrin-binding peptides.
Topics: Autoantigens; Collagen Type IV; Endothelial Cells; Humans; Integrin alphaVbeta3; Models, Biological; Neoplasm Proteins; Neoplasms; Neovascularization, Pathologic; Signal Transduction; Snake Venoms; Vascular Endothelial Growth Factor Receptor-2 | 2018 |
Molecular imaging of tumor-associated angiogenesis using a novel magnetic resonance imaging contrast agent targeting αvβ 3 integrin.
Topics: Animals; Colorectal Neoplasms; Contrast Media; Coordination Complexes; Feasibility Studies; Heterocyclic Compounds; HT29 Cells; Humans; Integrin alphaVbeta3; Magnetic Resonance Imaging; Mice; Mice, Nude; Molecular Imaging; Molecular Probes; Muscle, Skeletal; Neovascularization, Pathologic; Organometallic Compounds; Peptides, Cyclic; Snake Venoms | 2014 |
Integrin αvβ3 acting as membrane receptor for thyroid hormones mediates angiogenesis in malignant T cells.
Topics: Animals; Cell Line, Tumor; Cell Movement; Cell Proliferation; Female; Gene Expression Regulation, Neoplastic; Humans; Integrin alphaVbeta3; Jurkat Cells; Lymphoma, T-Cell; Male; Mice; Mice, SCID; Neoplasm Transplantation; Neovascularization, Pathologic; RNA, Small Interfering; Signal Transduction; Snake Venoms; T-Lymphocytes; Thyroid Hormones; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A | 2015 |
Dual-action combination therapy enhances angiogenesis while reducing tumor growth and spread.
Topics: Animals; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Lewis Lung; Cell Line, Tumor; Deoxycytidine; Drug Synergism; Gemcitabine; Humans; Lung; Mice; Mice, Inbred C57BL; Neoplasm Transplantation; Neovascularization, Pathologic; Pancreas; Pancreatic Neoplasms; Snake Venoms; Verapamil | 2015 |
CANCER. Tumor angiogenesis, from foe to friend.
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Hypoxia; Humans; Neoplasm Recurrence, Local; Neoplasms; Neovascularization, Pathologic; Snake Venoms | 2015 |
Will integrin inhibitors have proangiogenic effects in the clinic?
Topics: Animals; Glioblastoma; Humans; Integrins; Neovascularization, Pathologic; Snake Venoms | 2009 |
Radiation-induced modifications of the tumor microenvironment promote metastasis.
Topics: Angiogenesis Inhibitors; Cell Hypoxia; Cell Movement; Cell Proliferation; Cysteine-Rich Protein 61; Disease Progression; Endothelial Cells; Humans; Microvessels; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasm Proteins; Neoplasms; Neovascularization, Pathologic; Receptors, Vitronectin; Snake Venoms; Tumor Microenvironment | 2011 |
Cilengitide affects tumor compartment, vascularization and microenvironment in experimental bone metastases as shown by longitudinal ¹⁸F-FDG PET and gene expression analysis.
Topics: Animals; Biomarkers, Tumor; Bone Neoplasms; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Gene Expression Profiling; Humans; Integrin alphaVbeta3; Longitudinal Studies; Male; Neovascularization, Pathologic; Oligonucleotide Array Sequence Analysis; Positron-Emission Tomography; Radiopharmaceuticals; Rats; Rats, Nude; Real-Time Polymerase Chain Reaction; Receptors, Vitronectin; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Snake Venoms; Tumor Cells, Cultured; Tumor Microenvironment | 2013 |
Combination therapy of cilengitide with belotecan against experimental glioblastoma.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Brain Neoplasms; Camptothecin; Cell Line, Tumor; Cell Proliferation; Cell Survival; Glioblastoma; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Neovascularization, Pathologic; Snake Venoms; Topoisomerase I Inhibitors; Xenograft Model Antitumor Assays | 2013 |
Micro-MRI at 11.7 T of a murine brain tumor model using delayed contrast enhancement.
Topics: Anatomy, Cross-Sectional; Animals; Brain Neoplasms; Cell Line, Tumor; Contrast Media; Feasibility Studies; Female; Humans; Image Processing, Computer-Assisted; Imaging, Three-Dimensional; Injections, Intraperitoneal; Integrins; Magnetic Resonance Imaging; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Neovascularization, Pathologic; Peptides, Cyclic; Radiographic Image Enhancement; Snake Venoms; Time Factors; Transplantation, Heterologous | 2003 |
alphav beta 3 and alphav beta 5 integrin antagonists inhibit angiogenesis in vitro.
Topics: Angiogenesis Inhibitors; Animals; Biological Assay; Cattle; Cell Adhesion; Cell Culture Techniques; Cell Differentiation; Cell Movement; Cloning, Molecular; Collagen; Endothelium, Vascular; Fibrin; Fibroblast Growth Factor 2; Humans; Integrin alphaVbeta3; Integrins; Neovascularization, Pathologic; Neovascularization, Physiologic; Peptide Fragments; Peptides, Cyclic; Protein Structure, Tertiary; Receptors, Vitronectin; Snake Venoms; Vascular Endothelial Growth Factor A | 2003 |
Effect of the angiogenesis inhibitor Cilengitide (EMD 121974) on glioblastoma growth in nude mice.
Topics: Angiogenesis Inhibitors; Animals; Cell Line, Tumor; Dose-Response Relationship, Drug; Female; Glioblastoma; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Neovascularization, Pathologic; Snake Venoms; Treatment Outcome | 2006 |
Synergy between an antiangiogenic integrin alphav antagonist and an antibody-cytokine fusion protein eradicates spontaneous tumor metastases.
Topics: Animals; Antigens, CD; Colonic Neoplasms; Humans; Immunotherapy; Immunotoxins; Integrin alphaV; Interleukin-2; Melanoma, Experimental; Mice; Neoplasm Metastasis; Neovascularization, Pathologic; Neuroblastoma; Peptides, Cyclic; Receptors, Vitronectin; Recombinant Fusion Proteins; Snake Venoms; Tumor Cells, Cultured | 1999 |